SmartKem, Inc. (SMTK) - Q1 2026 Filing Summary
Business Context and Reporting Period
This summary covers the Unaudited Condensed Consolidated Financial Statements for SmartKem, Inc. for the quarterly period ended March 31, 2026. SmartKem is a smaller reporting company developing proprietary advanced semiconductor materials (TRUFLEX®) for display technologies. The company operates as a single segment focused on semiconductor materials, with R&D facilities in Manchester, UK, and a field office in Taiwan.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | $20,000 | $23,000 |
| Net Loss | $(19,369,000) | $(2,134,000) |
| Loss Per Share (Basic/Diluted) | $(1.34) | $(0.32) |
| Cash and Cash Equivalents (End of Period) | $7,566,000 | $3,881,000 |
| Net Cash Used in Operating Activities | $(1,572,000) | $(3,338,000) |
| Net Cash Provided by Financing Activities | $8,603,000 | $0 |
| Total Assets | $9,477,000 | $2,288,000 |
| Total Liabilities | $4,071,000 | $6,222,000 |
| Stockholders' Equity | $5,406,000 | $(3,934,000) |
Material Changes vs. Prior Period
- Significant Net Loss Increase: Net loss expanded from $2.1 million in Q1 2025 to $19.4 million in Q1 2026. This was driven primarily by non-operating expenses totaling $16.8 million, compared to non-operating income of $1.0 million in the prior year.
- Non-Operating Charges: The quarter included a $11.9 million loss on the execution of an Equity Line of Credit (ELOC), a $3.4 million change in fair value of derivative liabilities, and a $0.4 million loss on debt settlement.
- Operating Expense Reduction: Total operating expenses decreased by 23.1% to $2.6 million. R&D expenses dropped 39.0% to $0.9 million due to the termination of a CPI agreement and reduced legal costs following an IP transfer. G&A expenses decreased 17.2% to $1.7 million.
- Liquidity Improvement: Cash balances increased from $0.4 million at year-end 2025 to $7.6 million at March 31, 2026, following significant financing activities.
- Capital Structure Changes: The company issued Series A Preferred Stock, common stock via a Registered Direct Offering (RDO), and established an ELOC. Notes payable were significantly reduced through settlement and conversion.
Outlook, Risks, and Management Commentary
- Going Concern Warning: Management explicitly states there is substantial doubt about the company's ability to continue as a going concern. Current cash of $7.6 million is deemed insufficient to fund operations for the next 12 months. The company anticipates continued operating losses and will require additional capital to avoid curtailing operations or seeking bankruptcy protection.
- Financing Strategy: The company plans to fund operations through equity offerings (including the new ELOC), debt financings, and strategic alliances. Existing shareholders face likely dilution.
- Strategic Review: Management is reviewing its strategy, specifically evaluating display prototyping, materials formulation, and potential new materials. The company transferred its patent portfolio to a third party but retains 40 trade secrets regarding process and formulation.
- Internal Control Weakness: A material weakness in internal control over financial reporting was identified regarding the complex accounting for the ELOC and the lack of independent review of the control environment. Remediation is ongoing.
- Subsequent Events: Post-quarter, the company funded a $2.3 million bridge loan to Ferrox Critical Minerals and issued shares upon the exercise of Class C Warrants.
Investor Verification Checklist
- Cash Runway: Verify the specific timeline for the next capital raise given the "substantial doubt" disclosure and the $7.6 million cash balance.
- Dilution Impact: Assess the dilution effect of the 21.4 million common shares outstanding, 27.5 million warrants, and 21,411.5 shares of Series A Preferred Stock (convertible at $0.5812).
- Revenue Sustainability: Confirm the source of the $20k revenue (R&D grants/tax credits) and the viability of commercializing TRUFLEX® materials given the strategic review.
- Debt Obligations: Review the terms of the new ELOC and the remaining lease liabilities ($0.5 million) to understand immediate cash outflow requirements.
- IP Status: Clarify the implications of transferring the patent portfolio to a third party while retaining trade secrets.